Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Solid Tumor, Adult × Celecoxib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 29 Lung Neoplasms 22 Carcinoma, Non-Small-Cell Lung 22 Breast Neoplasms 22 Colonic Neoplasms 15 Head and Neck Neoplasms 13 Rectal Neoplasms 12 Prostatic Neoplasms 10 Sarcoma 8 Neoplasm Metastasis 8 Pancreatic Neoplasms 7 Esophageal Neoplasms 7 Neoplasms 6 Mouth Neoplasms 6 Glioblastoma 6 Adenomatous Polyposis Coli 6 Precancerous Conditions 5 Ovarian Neoplasms 5 Melanoma 5 Central Nervous System Neoplasms 5 Unspecified Adult Solid Tumor, Protocol Specific 4 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Recurrence 4 Neuroblastoma 4 Gliosarcoma 4 Carcinoma 4 Urinary Bladder Neoplasms 3 Oropharyngeal Neoplasms 3 Multiple Myeloma 3

Interventions

pembrolizumab 6 Radiotherapy 3 Proton Therapy 3 Interleukin-2 3 Cyclophosphamide 3 spartalizumab 2 fludarabine 2 Paclitaxel 2 Ipilimumab 2 Immune Checkpoint Inhibitors 2 Cetuximab 2 Carboplatin 2 Blood Specimen Collection 2 toripalimab 1 tislelizumab 1 sotorasib 1 peposertib 1 pazopanib 1 patritumab deruxtecan 1 palbociclib 1 niraparib 1 neotil 1 necitumumab 1 leronlimab 1 lenvatinib 1 atezolizumab 1 abemaciclib 1 Yoga 1 Valganciclovir 1 Trastuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03728179 2024-02-20

RACIN

Centre Hospitalier Universitaire Vaudois

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡